Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice

被引:41
作者
Azam, Faizul [1 ]
Alkskas, Ismail A. [1 ]
Ahmed, Musa A. [2 ]
机构
[1] Univ Seventh October, Fac Pharm, Dept Pharmaceut Chem, Misurata, Libya
[2] Al Arab Med Univ, Fac Pharm, Dept Med Chem, Benghazi, Libya
关键词
Parkinson's disease; Thiazolopyrimidine; Urea; Thiourea; Neuroprotection; FREE-RADICALS; POTENTIAL ANTICANCER; DOPAMINE AGONIST; REACTIVE OXYGEN; PRAMIPEXOLE; NEUROTOXICITY; DISCOVERY; AGENTS; NEUROPROTECTION; GLUTATHIONE;
D O I
10.1016/j.ejmech.2009.04.007
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A series of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7-yl urea and thiourea derivatives were designed and synthesized. All the compounds have been evaluated for their anti parkinsonian activity in catalepsy induced by haloperidol in mice. A majority of the compounds exhibited significant anti parkinsonian activity after intraperitoneal administration. The most active compound carries methoxy group at 2-position of the phenyl ring. Some of the potent compounds were selected for biochemical estimations of malondialdehyde, glutathione, superoxide dismutase and glutathione peroxidase from brain homogenate to highlight the neuroprotective properties associated with them. The results obtained in the present study may lead to the development of a suitable approach to the treatment of Parkinson's disease and may be the starting point for the future drug design. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3889 / 3897
页数:9
相关论文
共 63 条
[1]
Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[2]
Amir M, 2004, INDIAN J HETEROCY CH, V14, P119
[3]
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice [J].
Araki, T ;
Muramatsu, Y ;
Tanaka, K ;
Matsubara, M ;
Imai, Y .
NEUROSCIENCE LETTERS, 2001, 312 (01) :50-54
[4]
Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100
[5]
AZAM F, 2007, 10 INT CHEM C AFR 10
[6]
Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease [J].
Azam, Faizul ;
Barodia, Sandeep Kumar ;
Anwer, Tarique ;
Alam, M. M. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (03) :808-817
[7]
Synthesis of some urea and thiourea derivatives of naphtha[1,2-d]thiazol-2-amine as anti-Parkinsonian agents that cause neuroprotection against haloperidol-induced oxidative stress in mice [J].
Azam, Faizul .
MEDICINAL CHEMISTRY RESEARCH, 2009, 18 (04) :287-308
[8]
Synthesis of some novel N4-(naphtha[1,2-d]thiazol-2-yl)semicarbazides as potential anticonvulsants [J].
Azam, Faizul ;
Alkskas, Ismail A. ;
Khokra, Sukhbir Lal ;
Prakash, Om .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (01) :203-211
[9]
Neuroprotective effect of law dose riluzole in gerbil model of transient global ischemia [J].
Bae, HJ ;
Lee, YS ;
Kang, DW ;
Gu, JS ;
Yoon, BW ;
Roh, JK .
NEUROSCIENCE LETTERS, 2000, 294 (01) :29-32
[10]
Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease [J].
Bennett, JP ;
Piercey, MF .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) :25-31